PharmaSphere Consulting ApS: Financial statements 2022
CVR: 36696222
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
PharmaSphere Consulting ApS (CVR 36696222) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 916,030 and a net result of DKK 266,403 compared with DKK 87,666 the year before. That is an increase of 564.6% compared with the year before. Equity in the 2022 report amounted to DKK 316,838. The solvency ratio was 47.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 916,030
- Profit/Loss
- DKK 266,403
- Equity
- DKK 316,838
- Total Assets
- DKK 663,031
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 916 t. | 266 t. | 317 t. | 1 |
| 2021 | - | 138 t. | 88 t. | 138 t. | 1 |
| 2020 | - | 294 t. | 25 t. | 75 t. | 1 |
| 2019 | - | 383 t. | 248 t. | 300 t. | - |
| 2018 | - | 826 t. | 21 t. | 102 t. | - |
Official annual report
Keep an eye on PharmaSphere Consulting ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
PharmaSphere Consulting ApS has published its annual report for 2021. Gross profit came to DKK 137,828, and the net result was DKK 87,666.
About PharmaSphere Consulting ApS
PharmaSphere Consulting ApS is a Danish company of the type Anpartsselskab based in Ballerup, founded in 2015. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Søren Graves Truelsen. The company is owned by STruelsen-Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 2,479,823 and a net result of DKK 321,621 compared with DKK 688,490 the year before. Equity in the 2025 report amounted to DKK 466,582.